Latest news

  • Published On: September 22nd, 2022

    Stéphane Depil, founder and CEO of ErVaccine Technologies,  will give a talk  entitled “Human Endogenous Retrovirus  Represent a Source of Shared Tumor Epitopes Inducing High-Avidity Cytotoxic T cells for Cancer […]

  • Published On: September 22nd, 2022

    ErVaccine Technologies, in collaboration with Centre Leon Berard hospital / Cancer Research Center of Lyon, is thrilled to announce the selection of their research collaborative project (PRCE) grant proposal by […]

  • Published On: August 30th, 2022

    Download the job offer

    SENIOR COMPUTATIONAL BIOLOGIST POSITION

    Background

    ErVaccine Technologies is a start up company integrated in Centre Léon Bérard, Lyon, France, which develops new immunotherapeutic approaches targeting human endogenous retroviruses […]

  • Published On: June 29th, 2022

    ErVaccine Technologies, a preclinical-stage biotechnology company, announces the publication of a new paper in American Journal of Hematology‘HERVs characterize normal and leukemia stem cells […]

  • Published On: June 16th, 2022

    ErVaccine Technologies, a preclinical-stage biotechnology company, today announces the publication of a new paper in European Journal of Cancer journal: ‘Tumor burden and antigen-specific T cell magnitude represent major parameters […]

  • Published On: June 9th, 2022

    ErVaccine Technologies announces an endorsement from BPI (French Deeptech support) for a non-dilutive funding in the form of grants and repayable advances, for a total amount above 1.9 million€ on […]

  • Published On: June 1st, 2022

    ErVaccine announced a collaboration with two US companies: EVOQ Therapeutics, for the development of synthetic HDL NanoDiscs to deliver cancer vaccine candidates and Oncovir for the rights to use […]

  • Published On: April 4th, 2022

    Stéphane Depil, founder and CEO of ErVaccine Technologies,  will give a talk  entitled “Human Endogenous Retrovirus (HERVs) Represent a Source of Shared Tumour Epitopes Inducing High Avidity Cytotoxic T cells […]

Publications & Abstracts

  • Published On: June 28th, 2022
  • Published On: June 16th, 2022
  • Published On: January 27th, 2022
  • Published On: December 17th, 2021
  • Published On: November 12th, 2021
  • Published On: September 10th, 2021
  • Published On: May 10th, 2021
  • Published On: February 10th, 2021